Yuka Okuda

Immune‐Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non‐Small Cell Lung Cancer

Y. Koh, N. Yamamoto, Y. Ozawa, 2019, The oncologist.

Immune-Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non-Small Cell Lung Cancer.

Y. Koh, N. Yamamoto, Y. Ozawa, 2019, The oncologist.

CD24, not CD47, negatively impacts upon response to PD‐1/L1 inhibitors in non–small‐cell lung cancer with PD‐L1 tumor proportion score < 50

Y. Koh, N. Yamamoto, J. Fukuoka, 2020, Cancer science.

Impact of individual factors and personality trait on psychological problems of family members living with staff of a COVID‐19 frontline hospital: A cross‐sectional self‐administered anonymous questionnaire survey

Toshiko Matsuoka, S. Kimoto, R. Odachi, 2023, Psychiatry and Clinical Neurosciences Reports.

Efficacy of metyrapone for symptoms of adrenocortical carcinoma

T. Kawamata, T. Kuriyama, Yuka Okuda, 2023, BMJ supportive & palliative care.

A Case of Systemic Lupus Erythematosus Histologically Presented with Leucocytoclastic Vasculitis.

M. Isoda, Yuka Okuda, 1996 .